rosuvastatin glenmark 5 mg
glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg
rosuvastatin glenmark 10 mg
glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg
rosuvastatin glenmark 20 mg
glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
atorvastatin accord 10 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
atorvastatin accord 20 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg
atorvastatin accord 40 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg
atorvastatin accord 80 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg